A human interactome to prioritise drug discovery
Researchers create a network of interacting proteins – or interactome – to aid drug discovery.
2023
research-highlightsscience
Read the latest Issue
Finding coronavirus’s helper proteins
Science & Technology A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
2021
sciencescience-technology
Repurposing drugs for a pan-coronavirus treatment
Science & Technology Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three pathogenic coronaviruses. They also found potential drugs that could be repurposed as COVID-19 treatments, and against emerging coronavirus strains in the…
2020
sciencescience-technology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Science & Technology Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical trials
2020
sciencescience-technology
Identifying how potential COVID-19 drugs work
Science & Technology EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
2020
sciencescience-technology
Drivers of evolution hidden in plain sight
Science & Technology A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary process
2016
sciencescience-technology
EMBL-EBI hosts the Cambridge New Therapeutics Forum
Connections CamNTF hosts meetings around Cambridge, open to all scientists interested in new therapeutics
2016
connectionsevents
See data in a new light
Science & Technology 3D printing, gaming, virtual reality and lenticular posters bring new perspectives to research
2016
sciencescience-technology
No matching posts found
